Tetramer Formation of Tumor Suppressor Protein p53: Structure, Function, and Applications

被引:88
|
作者
Kamada, Rui [1 ]
Toguchi, Yu [1 ]
Nomura, Takao [2 ]
Imagawa, Toshiaki [1 ]
Sakaguchi, Kazuyasu [1 ]
机构
[1] Hokkaido Univ, Biol Chem Lab, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan
[2] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
关键词
cancer; tumor suppressor; oligomerization; structure; bio-nanomaterials; LI-FRAUMENI-SYNDROME; DNA-BINDING DOMAIN; CANCER-ASSOCIATED MUTANT; TP53 MUTATION DATABASE; S-ALKYL THIOESTER; C-TERMINAL DOMAIN; WILD-TYPE P53; OLIGOMERIZATION DOMAIN; CRYSTAL-STRUCTURE; NUCLEAR EXPORT;
D O I
10.1002/bip.22772
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tetramer formation of p53 is essential for its tumor suppressor function. p53 not only acts as a tumor suppressor protein by inducing cell cycle arrest and apoptosis in response to genotoxic stress, but it also regulates other cellular processes, including autophagy, stem cell self-renewal, and reprogramming of differentiated cells into stem cells, immune system, and metastasis. More than 50% of human tumors have TP53 gene mutations, and most of them are missense mutations that presumably reduce tumor suppressor activity of p53. This review focuses on the role of the tetramerization (oligomerization), which is modulated by the protein concentration of p53, posttranslational modifications, and/or interactions with its binding proteins, in regulating the tumor suppressor function of p53. Functional control of p53 by stabilizing or inhibiting oligomer formation and its bio-applications are also discussed. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:598 / 612
页数:15
相关论文
共 50 条
  • [31] The Tumor Suppressor p53: From Structures to Drug Discovery
    Joerger, Andreas C.
    Fersht, Alan R.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (06): : a000919
  • [32] The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway
    Liu, Juan
    Zhang, Cen
    Wang, Jianming
    Hu, Wenwei
    Feng, Zhaohui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 19
  • [33] Tumor suppressor p53 and its gain-of-function mutants in cancer
    Liu, Juan
    Zhang, Cen
    Feng, Zhaohui
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 46 (03) : 170 - 179
  • [34] Structural biology of the p53 tumour suppressor
    Okorokov, Andrei L.
    Orlova, Elena V.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2009, 19 (02) : 197 - 202
  • [35] Genetic deficiency of the tumor suppressor protein p53 influences erythrocyte survival
    Bissinger, Rosi
    Lang, Elisabeth
    Gonzalez-Menendez, Irene
    Quintanilla-Martinez, Leticia
    Ghashghaeinia, Mehrdad
    Pelzl, Lisann
    Sukkar, Basma
    Bhuyan, Abdulla Al Mamun
    Salker, Madhuri S.
    Singh, Yogesh
    Fehrenbacher, Birgit
    Fakhri, Hajar
    Umbach, Anja T.
    Schaller, Martin
    Qadri, Syed M.
    Lang, Florian
    APOPTOSIS, 2018, 23 (11-12) : 641 - 650
  • [36] Loss of Tumor Suppressor Protein p53 is linked to High Blood Pressure
    Liu, Jiao
    Li, Wencheng
    Li, Yuwen
    Chen, Tianjian
    El-Dahr, Samir
    Feng, Yumei
    Saifudeen, Zubaida
    HYPERTENSION, 2013, 62 (03)
  • [37] Detection of tumor suppressor protein p53 with special emphasis on biosensors: A review
    Deepa
    Pundir, Shikha
    Pundir, C. S.
    ANALYTICAL BIOCHEMISTRY, 2020, 588
  • [38] Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
    Hind Hafsi
    Daniela Santos-Silva
    Stéphanie Courtois-Cox
    Pierre Hainaut
    BMC Cancer, 13
  • [39] Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
    Hafsi, Hind
    Santos-Silva, Daniela
    Courtois-Cox, Stephanie
    Hainaut, Pierre
    BMC CANCER, 2013, 13
  • [40] Functional analysis of p53 tumor suppressor in yeast
    Smardová, J
    Smarda, J
    Koptíková, J
    DIFFERENTIATION, 2005, 73 (06) : 261 - 277